2017 MDMA Annual Meeting Agenda


*Speakers will be added as confirmed

Click Here for a PDF of the Agenda

Wednesday, April 26, 2017

3:00pm - 5:00pm - Pre-Registration Columbia A-B

Attendees are encouraged to come and pick up their meeting booklet, nametag and other information prior to the opening reception.

5:30pm - 7:00pm - Opening Reception - Thornton Room - 11th Floor

Enjoy networking with medical technology executives and other industry leaders while hearing from a leading policy maker on the state of play in Congress.

  • Congressman Erik Paulsen (MN-3rd District)

Thursday, April 27, 2017

7:15am - 7:40am - Networking Continental Breakfast

7:40am - 7:50am - Welcome Address Columbia A-B

MDMA's Chairman of the Board and MDMA's President & CEO will provide a review of Administration and Congressional activities, as well as the ongoing work with regulatory agencies to protect America's global leadership position in medical technology innovation.

  • Paul LaViolette, Board Chairman, MDMA, Executive Chairman, CardioFocus,
  • Mark Leahey, President & CEO, MDMA

7:50am - 8:00am - Opening/Technology Patient Address Columbia A-B

  • Eric Major, President & CEO, K2M, Inc.
  • Catherine Ross, Quality Control Manager, K2M, Inc.

8:00am - 8:30am - Keynote Address Columbia A-B

  • Congressman Greg Walden (OR - 2nd District), Chairman of the House Energy and Commerce Committee

8:30am - 8:50am - Keynote Address Columbia A-B

  • Senator Amy Klobuchar (MN)

8:50am - 9:35am -The Future of Medical Technology Innovation Columbia A-B

Advancements in technology continue to shift rapidly, and more integrated health care and delivery systems are presenting opportunities to for innovators to grow. Hear from some of the top executives in the device industry and how they are preparing for the future, and what you can do to take advantage of the changes in our ecosystem.

  • Andrew Cleeland, Chief Executive Officer, Fogarty Institute for Innovation
  • Mir Imran, Chairman, InCube Labs

9:35am - 10:00am - Networking Break

10:00am - 11:00am - CDRH Town Hall Columbia A-B

MDMA's popular interactive session will host the CDRH Director to answer your questions and share his insights on the evolving MDUFA IV agreement, the latest reforms at the agency, and what changes we can expect with a new FDA Commissioner and leadership.

  • Jeffrey Shuren, MD, Director, CDRH, FDA

11:00am - 11:45am - Medical Device Industry - Giving Back Columbia A-B

Med tech innovators have a proud history of not only transforming health care, but also addressing unmet challenges that impact patient populations and demographics throughout the world. Learn from several CEO's what they are doing to play their role in this tradition of giving back, and how each of you can join in this important work.

  • Senator Tom Harkin, Harkin Institute for Public Policy & Citizen Engagement, Drake University
  • Kristina Kaufmann, Executive Director, Code of Support Foundation
  • Joe Kiani, Chairman & Chief Executive Officer, Masimo Corporation
  • Eric Major, President & CEO, K2M, Inc.
  • Dan Moore, Chairman, LivaNova

11:45am - 12:00pm - Networking Break - Ballroom to be cleared for lunch

12:00pm - 1:15pm - Luncheon Address - 25 Years of MDMA Columbia A-B

Hear from some of MDMA's previous Chairs of the Board of Directors about the evolution of our industry's involvement with policy makers and tradition of passionate advocacy, and how these collective efforts over the years improved the med tech ecosystem.

  • Paul LaViolette, Board Chairman, MDMA, Executive Chairman, CardioFocus
  • Mark Leahey, President & CEO, MDMA (moderator)
  • Dan Moore, Chairman, LivaNova
  • Paul Touhey, former President & CEO, Fujirebio

1:15pm - 2:00pm - Building the Right Culture & Team to Lead Your Organization Columbia A-B

As your teams take on more responsibilities and face novel challenges in the business world - both in the United States and abroad - a leading med tech CEO will share proven approaches to building value for your investors while strengthening your teams and optimizing growth.

  • Benson Smith, Chairman, President & CEO, Teleflex, Inc.

2:00pm - 5:30pm - Congressional Fly-In

Congressional Fly-In Meeting participants will attend Hill meetings with their respective Senators and Representatives to discuss issues affecting the medical technology industry.

5:30pm - 7:00pm - Chairman's Reception Thornton Room - 11th Floor

Enjoy networking with medical technology executives, government officials and other industry leaders while honoring Members of Congress who have been strong voices to restore predictability and transparency in the regulatory process, improve the reimbursement landscape and repeal the medical device tax.

  • Congresswoman Elise Stefanik (NY - 21st District)
  • Congresswoman Mimi Walters (CA-45th District)
  • Senator Todd Young (IN)

Friday, April 28, 2017

7:30am - 8:15am - Networking Continental Breakfast

8:15am - 8:20am - Day Two Welcome Columbia A-B

  • Mark Leahey, President & CEO, MDMA

8:20am - 8:45am -Medtech Industry Update Columbia A-B

  • James Boylan, President, Head of Investment Banking, Leerink Partners

8:45am - 9:30am - Accelerating Patient Access to Technology Columbia A-B

A panel of government officials and med tech executives will discuss the best strategies to help ensure that patients are able to benefit from the cures and therapies being developed by our industry. This discussion will highlight various approaches innovators can take to expedite the process to secure fair and adequate reimbursement.

  • Elizabeth Halpern, Partner, Hogan Lovells (moderator)
  • Louis Jacques, Senior Vice President & Chief Clinical Officer, ADVI
  • Tamara Syrek Jensen, Director, Coverage and Analysis Group, CMS
  • Robert Stern, President, Vascular Dynamics, Inc.

9:30am - 10:15am - The Evolving Healthcare Ecosystem: How to Demonstrate Value & Improve Patient Outcomes Columbia A-B

As patient-centered health care and value-based models continue to evolve, it is becoming increasingly less clear what data and evidence med tech innovators should be looking to collect and provide. Representatives from the insurer, innovator and patient communities will share their perspectives, and discuss the best approaches to the new environment.

  • Lindsey McCandless, Director, ADVI
  • Paul Martino, Co-Founder & CSO, VillageMD
  • Michael Singer, Chief Executive Officer, BrainScope

10:15am - 10:30am - Networking Break

10:30am - 11:15am - When the Subpoena Arrives: Will your Compliance Program Measure Up? Columbia A-B

How effective is your compliance program? The ultimate test is a government investigation. In this role-playing exercise, a hypothetical medical device company with US and overseas sales will receive and react to a subpoena based on real-life investigations of alleged misconduct. Leading US and European legal experts will share key insights to the government's perspective on company interactions with health care professionals, compliance program operations, and the personal responsibility borne by company executives and board members.

  • Carolyn Bruguera, Vice President & General Counsel, MDMA
  • Peter Dieners, Partner, Clifford Chance
  • John Manthei, Partner, Latham & Watkins
  • Barry Sabin, Partner, Latham & Watkins

11:15am - 12:00pm - International Markets in Today's Environment Columbia A-B

The global marketplace for medical technologies continues to shift; with various events taking place throughout the world that are impacting the access to medical technology innovation.  From shifting political winds, trade negotiations, new Asian regulations and pricing pressures, and the EU’s latest regulations, hear from a panel of leading experts about how your team can adjust to this climate and maximize OUS growth.
  • Ames Gross, President, Pacific Bridge Medical
  • Ed Rozynski, Senior International Advisor, MDMA

12:00pm - Box Lunch/Departure


*The "Meet Your State Delegation on Capital Hill - Congressional Fly-In" is reserved for OEM medical device manufacturers. You must register for the Congressional Fly-in by March 31, 2017. If you are interested in participating or have questions, please contact Elliott Warren at ewarren@medicaldevices.org

Sessions and speakers are subject to change without notice. MDMA reserves the right to cancel or reschedule any program, whereupon full registration fees will be refunded or applied to the rescheduled program in accordance with the registrant's preference. In the event of canceled programs, MDMA assumes no responsibility for transportation, hotel, or other expenses incurred by registrants.